Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking
- PMID: 12807941
Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking
Abstract
It is now well established that infection with oncogenic human papillomavirus (HPV) types is the necessary cause of cervical cancer (CC) and its immediate precursor cervical intraepithelial neoplasia 3. However, HPV infection alone may not be sufficient to cause CC, and other exogenous and endogenous factors may exist that, in conjunction with HPV, influence the risk of progression from cervical HPV infection to CC. In this chapter, we review the evidence for the role of parity, oral contraceptive (OC) use, and tobacco smoking in CC. We also discuss limitations and methodologic problems encountered in assessing available data and outline recommendations for future research. Based on key studies on high-grade squamous intraepithelial lesions (HSILs) and CC conducted among HPV-positive women, it can be concluded that high parity, smoking, and less consistently long-term OC use are cofactors that may modulate the risk of progression from HPV infection to HSIL/CC. From a public health point of view, parity seems to be the behavioral cofactor explaining the highest proportion of CC cases among HPV-infected women. Smoking and long-term OC use may have a similar impact in populations that are heavily exposed to HPV and to these cofactors. Large prospective and retrospective cohort studies of HSIL and CC among middle-aged women in which several markers of HPV exposure are used and HPV persistence is documented would be valuable to study the role of these and other cofactors in HPV carcinogenesis. If confirmed, our conclusions may imply that multiparous women, women who are smokers, and women on long-term OC use may need closer surveillance for cytologic abnormalities and HPV infections than women in the general population.
Similar articles
-
Risk factors for cervical neoplasia in Denmark.APMIS Suppl. 1998;80:1-41. APMIS Suppl. 1998. PMID: 9693662
-
HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica.Br J Cancer. 2001 May 4;84(9):1219-26. doi: 10.1054/bjoc.2001.1779. Br J Cancer. 2001. PMID: 11336474 Free PMC article.
-
Risk factors of invasive cervical cancer in Morocco.Cell Mol Biol (Noisy-le-grand). 2009 Nov 15;55 Suppl:OL1175-85. Cell Mol Biol (Noisy-le-grand). 2009. PMID: 20003812
-
Environmental co-factors in HPV carcinogenesis.Virus Res. 2002 Nov;89(2):191-9. doi: 10.1016/s0168-1702(02)00188-0. Virus Res. 2002. PMID: 12445659 Review.
-
The epidemiology of genital human papillomavirus infection.Vaccine. 2006 Mar 30;24 Suppl 1:S1-15. doi: 10.1016/j.vaccine.2005.09.054. Vaccine. 2006. PMID: 16406226 Review.
Cited by
-
Involvement of Toll-like Receptor 9 polymorphism in cervical cancer development.Mol Biol Rep. 2012 Aug;39(8):8425-30. doi: 10.1007/s11033-012-1695-8. Epub 2012 Jun 20. Mol Biol Rep. 2012. PMID: 22714906 Free PMC article.
-
Cervical cancer in India and HPV vaccination.Indian J Med Paediatr Oncol. 2012 Jan;33(1):7-12. doi: 10.4103/0971-5851.96961. Indian J Med Paediatr Oncol. 2012. PMID: 22754202 Free PMC article.
-
Knowledge, attitude and uptake of human papillomavirus vaccination among female undergraduates in Lagos State, Nigeria.J Family Med Prim Care. 2019 Nov 15;8(11):3627-3633. doi: 10.4103/jfmpc.jfmpc_520_19. eCollection 2019 Nov. J Family Med Prim Care. 2019. PMID: 31803664 Free PMC article.
-
Tobacco Exposure Enhances Human Papillomavirus 16 Oncogene Expression via EGFR/PI3K/Akt/c-Jun Signaling Pathway in Cervical Cancer Cells.Front Microbiol. 2018 Dec 17;9:3022. doi: 10.3389/fmicb.2018.03022. eCollection 2018. Front Microbiol. 2018. PMID: 30619121 Free PMC article.
-
Knowledge of Human Papillomavirus and Cervical Cancer among Women Attending Gynecology Clinics in Pretoria, South Africa.Int J Environ Res Public Health. 2022 Apr 1;19(7):4210. doi: 10.3390/ijerph19074210. Int J Environ Res Public Health. 2022. PMID: 35409892 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical